Article
Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease
1 Jan 2014
Abstract excerpt
Myelodysplastic syndromes (MDS) are a group of clonal disorders arising from hematopoietic stem cells generally characterized by inefficient hematopoiesis, dysplasia in one or more myeloid cell lineages, and variable degrees of cytopenias. Most MDS patients are diagnosed in their late 60s to early 70s. The estimated incidence of MDS in the United States and in Europe are 4.3 and 1.8 per 100,000 individuals per...
Topics
Join the communities discussing this publication.